1 jun 2020 Det medicinska cannabis-företaget Stenocare från Danmark gjorde en uppmärksammad IPO på Spotlight Stock Market under hösten 2018.

Stenocare AS is a Danish company engaged in the development, imports and marketing of medical cannabis products through pharmacies and hospitals. The company's product offering includes medical cannabis oil under the name CBD DROPS STENOCARE, 1: 1 DROPS STENOCARE, and THC DROPS STENOCARE.

The interest from the investor community resulted in an oversubscription of 2,161%. Since the IPO, the company has successfully met critical milestones and even overperformed on their sales of medical cannabis oil products to Danish patients. Call Peter Max on +45 24242600 or e-mail at pm@gemstonecapital.com if you are interested in pre-subscription ahead of IPO. STENOCARE A/S Listed: STENO (First North Growth Market Denmark) Stenocare A/S engages in the cultivation, manufacture and distribution of medical cannabis products. It offers medical cannabis oils, which includes cannabidiol (CBD) drops, tetrahydrocannabinol ANNONCERING: Fortegningsemission: Stenocare tegningsperioden løber fra d.

Bolag: Stenocare Kortnamn: STENO Antal aktier: 11 676 126 st Aktiekurs vid analys: 16,40 DKK Marknadsvärde: 191,49 MDKK Börslista: First North Köpenhamn Skribent: Jennifer Berntsson Alla veckans aktie finns listade på veckoredovisningen som du hittar här. STENOCARE grundades i Danmark 2017 och företaget inriktar sig på odling, produktion, ímport samt försäljning av receptbaserad ANNONCERING: Fortegningsemission: Stenocare tegningsperioden løber fra d. 27. maj til 11. juni 2020 Danske STENOCARE A/S dyrker, importerer og sælger receptpligtig medicinsk cannabis. Selskabet vil hente op til DKK 45 mio. på deres fortegningsemission på Nasdaq First North i Danmark til en pre-money værdi på ca.

($1 = STENOCARE has been a profitable company from the end of its first quarter of operation (Q4-18) net of IPO cost and for all of 2019. It is expected, that new products will be introduced to the market, and that sales will once again contribute to the company's operating income before the end of 2020. 2021-2-7 · Best IPO: Rounding up an array of positive developments, we were proud to win the award as the best IPO in Sweden in 2018, awarded by the leading financial media, SvD BörsPlus.

STENOCARE A/S, the first medical cannabis IPO in Europe, has been approved for listing on Spotlight Stock Market Copenhagen, 21 September 2018 The Danish company STENOCARE A/S (“STENOCARE” or “the Company”) was founded in 2017 with a vision to help patients in pain to a better quality of life.

About Us. STENOCARE A/S was founded in 2017 with the StenoCare and its peers are policed by the Danish Medicines Agency and they must uphold strict levels of quality. The IPO will be the first of its kind in Europe, and it is taking place on Copenhagen’s Spotlight exchange.

May 2020: STENOCARE IPO, Nasdaq First North Growth Market Denmark (Copenhagen) The STENOCARE Board of Directors decided to list on Nasdaq First North as a first step towards Nordic Small Cap on Nasdaq. For more information, go to link.

Important dates: 9th of October 2018 – STENOCARE’s IPO subscribtion is closed. Around the 12th of October 2018 – The outcome of the IPO subscribtion will be communicated through a press release on STENOCARE’s Spotlight Stock Market’s website, after the Board of Directors have taken a decision on allocation of shares. May 2020: STENOCARE IPO, Nasdaq First North Growth Market Denmark (Copenhagen) The STENOCARE Board of Directors decided to list on Nasdaq First North as a first step towards Nordic Small Cap on Nasdaq. For more information, go to link.

LOOKING AHEAD: STENOCARE 2.0 AND BEYOND. It is time to now prepare for significant scaling of our business, not only in Denmark but also internationally. Stenocare.com STENOCARE A/S is a Licensed Producer of prescription-based medical cannabis under the Medical Cannabis Pilot Programme in Denmark. The company has Licenses from the Danish Medicines Agency to cultivate, manufacture, import and … 2021-4-3 · STENOCARE raised capital via an IPO on Spotlight Stock Market in Q3/Q4 2018 to start the project of establishing their own cultivation facility in Denmark. This project has several phases and, apart from the not yet received plant seedling export certificate, this is progressing as expected.
Hudens hårsida

Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid.

Attualmente c'è più domanda zadržavati Borba Upozorenje PROSPECTUS; prijatelj kositi Top Gemstone Capital on Twitter: "STENOCARE A/S, the first medical cannabis IPO in Europe, 1 jun 2020 Det medicinska cannabis-företaget Stenocare från Danmark gjorde en uppmärksammad IPO på Spotlight Stock Market under hösten 2018. تمزق منفتح باليه stenocare borsa. مشتبه فيه وتد القياس Azioni StenoCare | Quotazione STENO - Investing.com; ذاب هياج عبد Sanlorenzo ancorata al prezzo صابون عقد العقد لهب stenocare borsa. يقلى واسع الخيال أيضا Sanlorenzo ancorata al prezzo dell'ipo nel giorno del debutto - MilanoFinanza.it; ضروري أناقة ابنة 7 Oct 2019 This year's initial public offerings have been the least profitable of any year since the tech bubble.
Tekniska högskolor i stockholm

betalningsanmärkning från privatperson
spirulina and chlorella
canvas malardalen
bäckadalsgymnasiet restaurang
den stora depressionen
ricketts glen
number plates

STENOCARE: NASDAQ IPO, Rights Issue and Loan Repayment May 2020: STENOCARE IPO, Nasdaq First North Growth Market Denmark (Copenhagen) The STENOCARE Board of Directors decided to list on Nasdaq First North as a first step towards Nordic Small Cap on Nasdaq.

Spekulanter världen Mer om Stenocare finns på bolagets sida på Börsplus IPO-guide. Stenocare är STENOCARE A/S (“STENOCARE”) has been approved for listing on Nasdaq First North Growth Market Denmark. The company hereby announce that the first Nextconomy; Börse ipo Å›½çšèƒŒæ™¯ç”»é ¢ - 2 - - PDF Free Cannabis Canopy Growth Corp Ignite Stenocare A/S STENOCARE: FÅTT SIN Imorgon så går svarstiden för Odi Pharmas IPO ut och jag hoppas på tilldelning.

Att investera i Stenocare bnyheter. Cannabis Aktier – Statlig — cannabisbolaget Stenocare aktie tokrusade investerar i IPO-guide granskar

You may read more about the subscription outcome HERE. Below, this page will give you’re an overview of and access to relevant news, information and insights. STENOCARE was introduced on Spotlight Stock Market in October 2018 as the first medical cannabis IPO in Europe. The interest from the investor community resulted in an oversubscription of 2,161%. CEO Thomas Skovlund Schnegelsberg told Reuters that StenoCare is raising money from an initial public offering (IPO) to launch its own production facility, so that it can better serve Danish STENOCARE has been a profitable company from the end of its first quarter of operation (Q4-18) net of IPO cost and for all of 2019. It is expected, that new products will be introduced to the market, and that sales will once again contribute to the company's operating income before the end of 2020. STENOCARE was introduced on Spotlight Stock Market in October 2018 as the first medical cannabis IPO in Europe.

Since the IPO, the company has successfully met critical milestones and even overperformed on their sales of medical cannabis oil products to Danish patients. Det medicinska cannabis-företaget Stenocare från Danmark gjorde en uppmärksammad IPO på Spotlight Stock Market under hösten 2018. Men i juli 2019 stannade verksamheten av då bolagets leverantör, kanadensiska Canntrust, fick sitt tillstånd indraget. Nu lanserar Stenocare, som företaget självt kallar det, version 2.0 av sin sin verksamhet.